Published in Lancet on January 10, 2005
SIRS and Bacterial Sepsis Discrimination by Biomarkers in ICU (Captain) | NCT01378169
A Randomized Controlled Study of Enteral Nutrition in Septic Shock | NCT02025127
Evaluation of Early CRRT InTerventions in Patients With ECMO(ELITE) (ELITE) | NCT03549923
Immune Profile of Patients With Sepsis (IPSEPSIS) | NCT04163705
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet (2007) 4.23
PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci U S A (2009) 4.23
CISH and susceptibility to infectious diseases. N Engl J Med (2010) 3.31
Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry. PLoS One (2009) 3.23
Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med (2008) 2.93
MicroRNA-181b regulates NF-κB-mediated vascular inflammation. J Clin Invest (2012) 2.24
Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays. J Clin Microbiol (2009) 2.07
Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J Clin Invest (2008) 2.04
Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc Natl Acad Sci U S A (2009) 2.04
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage. Nat Immunol (2007) 1.95
Depressive symptoms in spouses of older patients with severe sepsis. Crit Care Med (2012) 1.78
Predicting high vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus bloodstream infections. Clin Infect Dis (2011) 1.78
Infection-associated clinical outcomes in hospitalized medical evacuees after traumatic injury: trauma infectious disease outcome study. J Trauma (2011) 1.77
Inhibition of MAP kinase/NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide nanoparticles. Biomaterials (2015) 1.74
Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med (2007) 1.69
Availability of critical care resources to treat patients with severe sepsis or septic shock in Africa: a self-reported, continent-wide survey of anaesthesia providers. Crit Care (2011) 1.67
Echocardiography practice, training and accreditation in the intensive care: document for the World Interactive Network Focused on Critical Ultrasound (WINFOCUS). Cardiovasc Ultrasound (2008) 1.55
SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J Clin Invest (2008) 1.48
Inflammation and oxidative stress in vertebrate host-parasite systems. Philos Trans R Soc Lond B Biol Sci (2009) 1.46
Endotoxin and β-1,3-d-Glucan in Concentrated Ambient Particles Induce Rapid Increase in Blood Pressure in Controlled Human Exposures. Hypertension (2015) 1.44
Design and conduct of the activated protein C and corticosteroids for human septic shock (APROCCHSS) trial. Ann Intensive Care (2016) 1.39
Impact of interleukin-10, soluble CD25 and interferon-γ on the prognosis and early diagnosis of bacteremic systemic inflammatory response syndrome: a prospective observational study. Crit Care (2013) 1.39
The effect of goal-directed therapy on mortality in patients with sepsis - earlier is better: a meta-analysis of randomized controlled trials. Crit Care (2014) 1.35
TLR4-induced IFN-gamma production increases TLR2 sensitivity and drives Gram-negative sepsis in mice. J Exp Med (2008) 1.32
Functions of the complement components C3 and C5 during sepsis. FASEB J (2008) 1.30
Delta neutrophil index as an early marker of disease severity in critically ill patients with sepsis. BMC Infect Dis (2011) 1.30
A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsis. EMBO Mol Med (2011) 1.28
Natural killer (NK) cells in antibacterial innate immunity: angels or devils? Mol Med (2012) 1.25
Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock. Crit Care (2012) 1.23
Sepsis-induced cardiomyopathy. Curr Cardiol Rev (2011) 1.21
Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure. Kidney Int (2006) 1.21
ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression. Nat Med (2011) 1.21
Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis. Crit Care (2009) 1.20
Catecholamines-crafty weapons in the inflammatory arsenal of immune/inflammatory cells or opening pandora's box? Mol Med (2008) 1.20
Fall in circulating mononuclear cell mitochondrial DNA content in human sepsis. Intensive Care Med (2010) 1.17
Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis. Crit Care (2011) 1.17
Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis. Crit Care (2009) 1.16
Rapid identification of Staphylococcus aureus in blood cultures by a combination of fluorescence in situ hybridization using peptide nucleic acid probes and flow cytometry. J Clin Microbiol (2005) 1.14
Rapid identification of bacterial pathogens in positive blood culture bottles by use of a broad-based PCR assay coupled with high-resolution melt analysis. J Clin Microbiol (2010) 1.14
Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis. Science (2015) 1.14
Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J Cachexia Sarcopenia Muscle (2010) 1.11
Melatonin: buffering the immune system. Int J Mol Sci (2013) 1.11
Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression. Clin Exp Immunol (2008) 1.11
CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs. FASEB J (2009) 1.10
Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes. Crit Care (2012) 1.10
Outer membrane vesicles derived from Escherichia coli induce systemic inflammatory response syndrome. PLoS One (2010) 1.10
Symptoms of depression in survivors of severe sepsis: a prospective cohort study of older Americans. Am J Geriatr Psychiatry (2013) 1.09
Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohorts. Crit Care (2010) 1.08
Mesenchymal stromal cells improve survival during sepsis in the absence of heme oxygenase-1: the importance of neutrophils. Stem Cells (2013) 1.08
Sedation improves early outcome in severely septic Sprague Dawley rats. Crit Care (2009) 1.07
Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide Pep19-2.5 on bacterial pathogenicity factors. Antimicrob Agents Chemother (2013) 1.06
Role of miR-181 family in regulating vascular inflammation and immunity. Trends Cardiovasc Med (2013) 1.06
Actinonin, a meprin A inhibitor, protects the renal microcirculation during sepsis. Shock (2011) 1.05
Timing of vasopressor initiation and mortality in septic shock: a cohort study. Crit Care (2014) 1.05
The causes and treatment outcomes of 91 patients with adult nosocomial meningitis. Korean J Intern Med (2012) 1.04
Corticosteroids for severe sepsis: an evidence-based guide for physicians. Ann Intensive Care (2011) 1.04
Continuous hemodiafiltration with PMMA Hemofilter in the treatment of patients with septic shock. Mol Med (2008) 1.03
Role of haem oxygenase-1 in microbial host defence. Cell Microbiol (2008) 1.03
Lipopolysaccharide-induced Notch signaling activation through JNK-dependent pathway regulates inflammatory response. J Biomed Sci (2011) 1.03
The role of natural killer cells in sepsis. J Biomed Biotechnol (2011) 1.02
Rapid detection of methicillin-resistant staphylococci by real-time PCR directly from positive blood culture bottles. Eur J Clin Microbiol Infect Dis (2007) 1.01
Inhibition of c-Jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction. J Biol Chem (2011) 1.00
Bloodstream infections among human immunodeficiency virus-infected adult patients: epidemiology and risk factors for mortality. Eur J Clin Microbiol Infect Dis (2008) 0.99
Thrombocytopenia in Staphylococcus aureus bacteremia: risk factors and prognostic importance. Mayo Clin Proc (2011) 0.99
LECT2 protects mice against bacterial sepsis by activating macrophages via the CD209a receptor. J Exp Med (2012) 0.99
Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis. Crit Care (2012) 0.98
A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice. Br J Pharmacol (2009) 0.97
Performance of Kiestra total laboratory automation combined with MS in clinical microbiology practice. Ann Lab Med (2014) 0.93
Fluid management and risk factors for renal dysfunction in patients with severe sepsis and/or septic shock. Crit Care (2012) 0.93
Clinical predictors and outcome of metabolic acidosis in under-five children admitted to an urban hospital in Bangladesh with diarrhea and pneumonia. PLoS One (2012) 0.93
The stressed host response to infection: the disruptive signals and rhythms of systemic inflammation. Surg Clin North Am (2009) 0.92
Comparison of severity of illness scoring systems for patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa. BMC Infect Dis (2006) 0.92
Acceleration of the direct identification of Staphylococcus aureus versus coagulase-negative staphylococci from blood culture material: a comparison of six bacterial DNA extraction methods. Eur J Clin Microbiol Infect Dis (2010) 0.92
B and T lymphocyte attenuator inhibits LPS-induced endotoxic shock by suppressing Toll-like receptor 4 signaling in innate immune cells. Proc Natl Acad Sci U S A (2013) 0.91
Interleukin-1 receptor-associated kinase M-deficient mice demonstrate an improved host defense during Gram-negative pneumonia. Mol Med (2012) 0.91
Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study. Crit Care (2015) 0.90
Developments for improved diagnosis of bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis (2014) 0.90
Evaluation of the effects of ozone therapy in the treatment of intra-abdominal infection in rats. Clinics (Sao Paulo) (2010) 0.90
Risk factors for death after sepsis in patients immunosuppressed before the onset of sepsis. Scand J Infect Dis (2009) 0.90
Statins in the critically ill. Ann Intensive Care (2012) 0.90
Platelet and neutrophil responses to Gram positive pathogens in patients with bacteremic infection. PLoS One (2011) 0.89
Norepinephrine weaning in septic shock patients by closed loop control based on fuzzy logic. Crit Care (2008) 0.89
NOD2-mediated suppression of CD55 on neutrophils enhances C5a generation during polymicrobial sepsis. PLoS Pathog (2013) 0.89
Sepsis-induced myocardial dysfunction: pathophysiology and management. J Intensive Care (2016) 0.89
Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multicenter randomised controlled clinical trial. BMJ Open (2014) 0.88
Innate immunity and inflammation--two facets of the same anti-infectious reaction. Clin Exp Immunol (2009) 0.88
Preconditioning with ozone/oxygen mixture induces reversion of some indicators of oxidative stress and prevents organic damage in rats with fecal peritonitis. Inflamm Res (2009) 0.88
Clinical characteristics and risk factors for septic shock in patients receiving emergency drainage for acute pyelonephritis with upper urinary tract calculi. BMC Urol (2012) 0.88
Procalcitonin levels to guide antibiotic therapy in adults with non-microbiologically proven apparent severe sepsis: a randomised controlled trial. BMJ Open (2013) 0.88
The antifungal agent itraconazole induces the accumulation of high mannose glycoproteins in macrophages. J Biol Chem (2009) 0.88
Oral and systemic administration of beta-glucan protects against lipopolysaccharide-induced shock and organ injury in rats. Clin Exp Immunol (2007) 0.87
Automated electronic medical record sepsis detection in the emergency department. PeerJ (2014) 0.87
LPS pretreatment ameliorates multiple organ injuries and improves survival in a murine model of polymicrobial sepsis. Inflamm Res (2011) 0.87
Practical aspects of treatment with drotrecogin alfa (activated). Crit Care (2007) 0.87
Protein C promoter polymorphisms associate with sepsis in children with systemic meningococcemia. Hum Genet (2007) 0.87
Lack of effect of oral administration of resveratrol in LPS-induced systemic inflammation. Eur J Nutr (2011) 0.86
Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release. Am J Respir Crit Care Med (2012) 0.86
Carbon Monoxide Improves Efficacy of Mesenchymal Stromal Cells During Sepsis by Production of Specialized Proresolving Lipid Mediators. Crit Care Med (2016) 0.86
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA (2002) 16.37
Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet (2007) 4.81
Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA (2009) 4.73
12-h pretreatment with methylprednisolone versus placebo for prevention of postextubation laryngeal oedema: a randomised double-blind trial. Lancet (2007) 3.80
Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation (2002) 3.16
Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med (2006) 2.69
Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages. J Leukoc Biol (2009) 2.45
Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ (2004) 2.39
The effect of waiving consent on enrollment in a sepsis trial. Intensive Care Med (2004) 2.34
Compensatory anti-inflammatory response syndrome. Thromb Haemost (2009) 2.31
Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med (2008) 2.17
Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur J Immunol (2005) 1.90
Recombinant human activated protein C for adults with septic shock: a randomized controlled trial. Am J Respir Crit Care Med (2013) 1.81
Prevention of acquired infections in intubated patients with the combination of two decontamination regimens. Crit Care Med (2005) 1.77
Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med (2007) 1.74
Resilience to bacterial infection: difference between species could be due to proteins in serum. J Infect Dis (2010) 1.73
Does the shape of lipid A determine the interaction of LPS with Toll-like receptors? Trends Immunol (2002) 1.72
Effect of oropharyngeal povidone-iodine preventive oral care on ventilator-associated pneumonia in severely brain-injured or cerebral hemorrhage patients: a multicenter, randomized controlled trial. Crit Care Med (2014) 1.56
Lung microenvironment contributes to the resistance of alveolar macrophages to develop tolerance to endotoxin*. Crit Care Med (2012) 1.49
Tamsulosin hydrochloride vs placebo for management of distal ureteral stones: a multicentric, randomized, double-blind trial. Arch Intern Med (2010) 1.46
Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection. Am J Respir Crit Care Med (2014) 1.45
Cutting edge: crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1- invariant NKT cells to bacteria. J Immunol (2010) 1.44
Short-term decline in all-cause acquired infections with the routine use of a decontamination regimen combining topical polymyxin, tobramycin, and amphotericin B with mupirocin and chlorhexidine in the ICU: a single-center experience. Crit Care Med (2014) 1.41
Natural killer (NK) cells in antibacterial innate immunity: angels or devils? Mol Med (2012) 1.25
Stress molecules in sepsis and systemic inflammatory response syndrome. FEBS Lett (2007) 1.24
Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients. Crit Care Med (2006) 1.19
Contribution of phagocytosis and intracellular sensing for cytokine production by Staphylococcus aureus-activated macrophages. Infect Immun (2006) 1.19
Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis. Am J Physiol Lung Cell Mol Physiol (2003) 1.16
Corticosteroids in sepsis: from bench to bedside? Shock (2003) 1.15
LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-kappaB activation. J Biol Chem (2006) 1.12
Compartmentalization of tolerance to endotoxin. J Infect Dis (2004) 1.12
Toll-like receptor-mediated tumor necrosis factor and interleukin-10 production differ during systemic inflammation. Am J Respir Crit Care Med (2003) 1.11
The WalKR system controls major staphylococcal virulence genes and is involved in triggering the host inflammatory response. Infect Immun (2012) 1.09
Increased plasma levels of soluble triggering receptor expressed on myeloid cells 1 and procalcitonin after cardiac surgery and cardiac arrest without infection. Shock (2007) 1.09
Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care (2007) 1.08
In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosis. BMC Microbiol (2010) 1.07
Clostridium sordellii lethal toxin kills mice by inducing a major increase in lung vascular permeability. Am J Pathol (2007) 1.06
Sequential methods and group sequential designs for comparative clinical trials. Fundam Clin Pharmacol (2003) 1.04
DNAemia detection by multiplex PCR and biomarkers for infection in systemic inflammatory response syndrome patients. PLoS One (2012) 1.03
Bench-to-bedside review: Platelets and active immune functions - new clues for immunopathology? Crit Care (2013) 1.02
Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock. Clin Pharmacol Ther (2002) 1.00
Contribution of NOD2 to lung inflammation during Staphylococcus aureus-induced pneumonia. Microbes Infect (2010) 1.00
Early events in innate immunity in the recognition of microbial pathogens. Expert Opin Biol Ther (2007) 1.00
Neutrophils in cystic fibrosis display a distinct gene expression pattern. Mol Med (2008) 1.00
Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors. Int Immunol (2003) 0.99
Clinical pharmacology, efficacy and safety of atazanavir: a review. Expert Opin Drug Metab Toxicol (2009) 0.99
Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application. Clin Chem Lab Med (2010) 0.98
Toll-like receptors expression and interferon-γ production by NK cells in human sepsis. Crit Care (2012) 0.98
Effects of aging and menopause on serum interleukin-6 levels and peripheral blood mononuclear cell cytokine production in healthy nonobese women. Age (Dordr) (2011) 0.98
Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammation. Crit Care (2010) 0.97
Corticosteroids for treating sepsis. Cochrane Database Syst Rev (2015) 0.96
The Bw cells, a novel B cell population conserved in the whole genus Mus. J Immunol (2007) 0.93
NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis. J Immunol (2012) 0.92
Simple method for repurification of endotoxins for biological use. Appl Environ Microbiol (2007) 0.92
Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaB. J Cell Mol Med (2007) 0.91
Biofilm-forming Pseudomonas aeruginosa bacteria undergo lipopolysaccharide structural modifications and induce enhanced inflammatory cytokine response in human monocytes. Innate Immun (2009) 0.89
Adherence influences monocyte responsiveness to interleukin-10. J Leukoc Biol (2003) 0.89
Randomized comparison of 2 protocols to prevent acquisition of methicillin-resistant Staphylococcus aureus: results of a 2-center study involving 500 patients. Infect Control Hosp Epidemiol (2011) 0.88
Dopexamine and norepinephrine versus epinephrine on gastric perfusion in patients with septic shock: a randomized study [NCT00134212]. Crit Care (2006) 0.88
Early systemic bacterial dissemination and a rapid innate immune response characterize genetic resistance to plague of SEG mice. J Infect Dis (2011) 0.88
CD24-triggered caspase-dependent apoptosis via mitochondrial membrane depolarization and reactive oxygen species production of human neutrophils is impaired in sepsis. J Immunol (2014) 0.88
Day and nighttime excretion of 6-sulphatoxymelatonin in adolescents and young adults with autistic disorder. Psychoneuroendocrinology (2012) 0.87
Immune status and apoptosis activation during brain death. Shock (2010) 0.86
Adherence modifies the regulation of gene expression induced by interleukin-10. Cytokine (2005) 0.85
Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives. Int J Mol Sci (2013) 0.85
Mechanisms of TNF induction by heat-killed Staphylococcus aureus differ upon the origin of mononuclear phagocytes. Am J Physiol Cell Physiol (2011) 0.84
Translocation of bacterial NOD2 agonist and its link with inflammation. Crit Care (2009) 0.84
Circulating and airway neutrophils in cystic fibrosis display different TLR expression and responsiveness to interleukin-10. Cytokine (2007) 0.84
Interferon-γ and granulocyte/monocyte colony-stimulating factor production by natural killer cells involves different signaling pathways and the adaptor stimulator of interferon genes (STING). J Biol Chem (2013) 0.84
Corticoids normalize leukocyte production of macrophage migration inhibitory factor in septic shock. J Infect Dis (2004) 0.84
Bordetella pertussis adenylate cyclase-hemolysin induces interleukin-6 secretion by human tracheal epithelial cells. Infect Immun (2004) 0.83
Effect of an anesthesia with propofol compared with desflurane on free radical production and liver function after partial hepatectomy. Fundam Clin Pharmacol (2011) 0.82
Host response biomarkers in the diagnosis of sepsis: a general overview. Methods Mol Biol (2015) 0.82
Richard Pfeiffer and Alexandre Besredka: creators of the concept of endotoxin and anti-endotoxin. Microbes Infect (2003) 0.81
"Septic Plasma": an immunosuppressive milieu. Am J Respir Crit Care Med (2002) 0.81
5-HT activates ERK MAP kinase in cultured-human peripheral blood mononuclear cells via 5-HT1A receptors. Life Sci (2004) 0.80
Efficacy and safety of Celsior preservation fluid in liver transplantation: one-year follow up of a prospective, multicenter, non-randomized study. Clin Transplant (2011) 0.80
Bench-to-bedside review: Natural killer cells in sepsis - guilty or not guilty? Crit Care (2013) 0.80
Sepsis mediators. Curr Infect Dis Rep (2007) 0.79
Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of four triazole antifungal agents in human plasma. Clin Chem Lab Med (2010) 0.79
beta2-Adrenoceptor blockade partially restores ex vivo TNF production following hemorrhagic shock. Cytokine (2006) 0.78
Hemodynamic and histomorphometric characteristics of heart failure induced by aortic stenosis in the guinea pig: comparison of two constriction sizes. Can J Physiol Pharmacol (2009) 0.78
Wild-derived mouse strains, a valuable model to study B cell responses. Mol Immunol (2008) 0.78
Combined effects of metoprolol and spironolactone in dilated cardiomyopathic hamsters. J Cardiovasc Pharmacol (2002) 0.77
Polymyxin B for endotoxin removal in sepsis. Lancet Infect Dis (2011) 0.77
Gluco- and mineralocorticoid biological effects of a 7-day treatment with low doses of hydrocortisone and fludrocortisone in septic shock. Intensive Care Med (2012) 0.77
Is boosting the immune system in sepsis appropriate? Crit Care (2014) 0.77
Direct effects of 3 combinations of enalapril, metoprolol, and spironolactone on cardiac remodeling in dilated cardiomyopathic hamsters. J Card Fail (2006) 0.77
Meta-analysis of interstitial pneumonia in studies evaluating iodine-131-labeled lipiodol for hepatocellular carcinoma using exact likelihood approach. Pharmacoepidemiol Drug Saf (2011) 0.77
Influence of resuscitation volume on blood cells TNF production in a murine model of haemorrhage. Resuscitation (2005) 0.76
The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: a randomized controlled trial. J Infect (2013) 0.76
Combined effects of enalapril and spironolactone in hamsters with dilated cardiomyopathy. J Cardiovasc Pharmacol (2003) 0.76
Low doses of fludrocortisone and hydrocortisone, alone or in combination, on vascular responsiveness to phenylephrine in healthy volunteers. Br J Clin Pharmacol (2013) 0.75
Opportunity to monitor immunosuppressive drugs in peripheral blood mononuclear cells: where are we and where are we going? Pharmacol Res (2013) 0.75
Melatonin: pharmacology, functions and therapeutic benefits. Curr Neuropharmacol (2016) 0.75
An ex vivo model to decipher the impact of extracorporeal membrane oxygenation on beta-lactam degradation kinetics. Ther Drug Monit (2016) 0.75
Endotoxin and anti-endotoxin. The contribution of the schools of Koch and Pasteur: life, milestone-experiments and concepts of Richard Pfeiffer (Berlin) and Alexandre Besredka (Paris). J Endotoxin Res (2002) 0.75
Endotoxin and anti-endotoxin. The contribution of the schools of Koch and Pasteur: life, milestone-experiments and concepts of Richard Pfeiffer (Berlin) and Alexandre Besredka (Paris). J Endotoxin Res (2002) 0.75
Managing Drug-Drug Interaction Between Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir, and Mycophenolate Mofetil. Ther Drug Monit (2017) 0.75